Literature DB >> 20864931

Assessment of immunologically relevant dynamic tertiary structural features of the HIV-1 V3 loop crown R2 sequence by ab initio folding.

David Almond1, Timothy Cardozo.   

Abstract

The antigenic diversity of HIV-1 has long been an obstacle to vaccine design, and this variability is especially pronounced in the V3 loop of the virus' surface envelope glycoprotein. We previously proposed that the crown of the V3 loop, although dynamic and sequence variable, is constrained throughout the population of HIV-1 viruses to an immunologically relevant β-hairpin tertiary structure. Importantly, there are thousands of different V3 loop crown sequences in circulating HIV-1 viruses, making 3D structural characterization of trends across the diversity of viruses difficult or impossible by crystallography or NMR. Our previous successful studies with folding of the V3 crown used the ab initio algorithm accessible in the ICM-Pro molecular modeling software package (Molsoft LLC, La Jolla, CA) and suggested that the crown of the V3 loop, specifically from positions 10 to 22, benefits sufficiently from the flexibility and length of its flanking stems to behave to a large degree as if it were an unconstrained peptide freely folding in solution. As such, rapid ab initio folding of just this portion of the V3 loop of any individual strain of the 60,000+ circulating HIV-1 strains can be informative. Here, we folded the V3 loop of the R2 strain to gain insight into the structural basis of its unique properties. R2 bears a rare V3 loop sequence thought to be responsible for the exquisite sensitivity of this strain to neutralization by patient sera and monoclonal antibodies. The strain mediates CD4-independent infection and appears to elicit broadly neutralizing antibodies. We demonstrate how evaluation of the results of the folding can be informative for associating observed structures in the folding with the immunological activities observed for R2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864931      PMCID: PMC3157871          DOI: 10.3791/2118

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response.

Authors:  G V Quinnan; P F Zhang; D W Fu; M Dong; H J Alter
Journal:  AIDS Res Hum Retroviruses       Date:  1999-04-10       Impact factor: 2.205

2.  A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.

Authors:  Peng Fei Zhang; Peter Bouma; Eun Ju Park; Joseph B Margolick; James E Robinson; Susan Zolla-Pazner; Michael N Flora; Gerald V Quinnan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

Authors:  R Abagyan; M Totrov
Journal:  J Mol Biol       Date:  1994-01-21       Impact factor: 5.469

4.  Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop.

Authors:  David Almond; Tetsuya Kimura; XiangPeng Kong; James Swetnam; Susan Zolla-Pazner; Timothy Cardozo
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

  4 in total
  8 in total

1.  Unbiased Identification of Immunogenic Staphylococcus aureus Leukotoxin B-Cell Epitopes.

Authors:  David N Hernandez; Kayan Tam; Bo Shopsin; Emily E Radke; Pegah Kolahi; Richard Copin; François-Xavier Stubbe; Timothy Cardozo; Victor J Torres; Gregg J Silverman
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.

Authors:  Androo J Markham; Sara E Rasmussen; Jane E Salmon; Wilnelly Martinez-Ortiz; Timothy J Cardozo; Robert M Clancy; Jill P Buyon
Journal:  J Am Heart Assoc       Date:  2015-05-20       Impact factor: 5.501

3.  Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.

Authors:  Boonrat Tassaneetrithep; Doreen Tivon; James Swetnam; Nicos Karasavvas; Nelson L Michael; Jerome H Kim; Mary Marovich; Timothy Cardozo
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure.

Authors:  Mohammed S Aiyegbo; Evgeny Shmelkov; Lorenzo Dominguez; Michael Goger; Shibani Battacharya; Allan C deCamp; Peter B Gilbert; Phillip W Berman; Timothy Cardozo
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.

Authors:  Catarina E Hioe; Rajnish Kumar; Chitra Upadhyay; Muzafar Jan; Alisa Fox; Vincenza Itri; Kristina K Peachman; Mangala Rao; Lily Liu; Nathan C Lo; Michael Tuen; Xunqing Jiang; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

6.  Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.

Authors:  Susan Zolla-Pazner; Sandra Sharpe Cohen; David Boyd; Xiang-Peng Kong; Michael Seaman; Michel Nussenzweig; Florian Klein; Julie Overbaugh; Max Totrov
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

7.  An ID2-dependent mechanism for VHL inactivation in cancer.

Authors:  Sang Bae Lee; Veronique Frattini; Mukesh Bansal; Angelica M Castano; Dan Sherman; Keino Hutchinson; Jeffrey N Bruce; Andrea Califano; Guangchao Liu; Timothy Cardozo; Antonio Iavarone; Anna Lasorella
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

8.  Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.

Authors:  David N Hernandez; Kayan Tam; Bo Shopsin; Emily E Radke; Karen Law; Timothy Cardozo; Victor J Torres; Gregg J Silverman
Journal:  mBio       Date:  2020-06-16       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.